ConductScience.org, home

Paper35528971

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.

Kaya E and 1 other. J Clin Transl Hepatol, 2022. Cited by 165 papers, by iCite.

Cite this record

ConductScience Library. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Papers, record 35528971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35528971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
PubMed
Journal
J Clin Transl Hepatol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
165
iCite
Relative citation ratio, by iCite
14.4
iCite
Revised in PubMed
2024-08-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaya EEdahttps://orcid.org/0000-0002-9293-2811
2Yilmaz YYusufhttps://orcid.org/0000-0003-4518-5283

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References148

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126707365Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016https://conductscience.org/library/papers/26707365PubMed
229150142Association between non-alcoholic fatty liver disease and cancer incidence rate.J Hepatol2017https://conductscience.org/library/papers/29150142PubMed
332696080NAFLD and cardiovascular diseases: a clinical review.Clin Res Cardiol2021https://conductscience.org/library/papers/32696080PubMed
432598051Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.Aliment Pharmacol Ther2020https://conductscience.org/library/papers/32598051PubMed
525125077Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.Hepatology2015https://conductscience.org/library/papers/25125077PubMed
632059982NAFLD as a driver of chronic kidney disease.J Hepatol2020https://conductscience.org/library/papers/32059982PubMed
731098621The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance.Endocr Rev2019https://conductscience.org/library/papers/31098621PubMed
829935236Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.Metabolism2018https://conductscience.org/library/papers/29935236PubMed
929286050Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.Nat Rev Endocrinol2018https://conductscience.org/library/papers/29286050PubMed
1026791408The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women.J Transl Med2016https://conductscience.org/library/papers/26791408PubMed
1131786360Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.Diabetes Metab2020https://conductscience.org/library/papers/31786360PubMed
1228674631Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.Open Heart2017https://conductscience.org/library/papers/28674631PubMed
1326636408Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.Eur J Gastroenterol Hepatol2016https://conductscience.org/library/papers/26636408PubMed
1431627243Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis.Liver Int2020https://conductscience.org/library/papers/31627243PubMed
1531512278Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.J Gastroenterol Hepatol2020https://conductscience.org/library/papers/31512278PubMed
1620369224Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients.Diabetologia2010https://conductscience.org/library/papers/20369224PubMed
1729122391Genetics and epigenetics of NAFLD and NASH: Clinical impact.J Hepatol2018https://conductscience.org/library/papers/29122391PubMed
1822183820Prevalence of hypothyroidism in nonalcoholic fatty liver disease.Dig Dis Sci2012https://conductscience.org/library/papers/22183820PubMed
1925386164Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.Front Endocrinol (Lausanne)2014https://conductscience.org/library/papers/25386164PubMed
2031470068The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.J Hepatol2019https://conductscience.org/library/papers/31470068PubMed

See all 148 referencesDownload CSV of references

Cited by130

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.

PMIDTitleJournalYearIn PapersSource
42931549Eco-Environmental, Health and Socio-Economic Perspectives on Cyanobacteria and Cyanotoxins.Toxins (Basel)2026https://conductscience.org/library/papers/42931549PubMed
42845096Metabolic Dysfunction-Associated Steatohepatitis and the Progression of Cognitive Decline in Older Thai People With HIV.J Int AIDS Soc2026https://conductscience.org/library/papers/42845096PubMed
42761919Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future Perspectives.Drug Des Devel Ther2026https://conductscience.org/library/papers/42761919PubMed
42737722From Molecular Mechanisms to Clinical Strategies: A Comprehensive Overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Int J Mol Sci2026https://conductscience.org/library/papers/42737722PubMed
42718610Atherogenic index of plasma as a simple marker for NAFLD risk stratification in community-dwelling older adults: a cross-sectional study with incremental predictive value assessment.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42718610PubMed
42701513Validation of voxel-based computed tomography liver fat quantification for assessing incident type 2 diabetes risk in a health check-up population.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42701513PubMed
42649512Association between low skeletal muscle mass assessed by deep learning-based CT and MASLD: a prospective cohort study.Diabetol Metab Syndr2026https://conductscience.org/library/papers/42649512PubMed
42609490TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD).Hepatol Forum2026https://conductscience.org/library/papers/42609490PubMed
42602603Association of hepatic steatosis with MRI-defined renal steatosis in type 2 diabetes: a cross-sectional imaging and clinical modeling study.Front Nutr2026https://conductscience.org/library/papers/42602603PubMed
42559181ZRSR1 protects against obesity-associated hepatic lipogenesis independent of minor intron splicing.Life Metab2026https://conductscience.org/library/papers/42559181PubMed
42514401ZFP90 Serves as a Transcriptional Brake on NF-κB Signaling to Attenuate Diet-Induced MASLD Progression.Nutrients2026https://conductscience.org/library/papers/42514401PubMed
42483063Association between occupational noise exposure and metabolic dysfunction-associated fatty liver disease: the mediating role of body mass index in automotive manufacturing workers.Front Public Health2026https://conductscience.org/library/papers/42483063PubMed
42458273Development and validation of an online dynamic nomogram for nonobese metabolic dysfunction-associated steatotic liver disease based on body composition analysis.BMC Gastroenterol2026https://conductscience.org/library/papers/42458273PubMed
42373436[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42373436PubMed
42290708Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study.Ther Adv Endocrinol Metab2026https://conductscience.org/library/papers/42290708PubMed
42120765The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and Dementia.J Mol Neurosci2026https://conductscience.org/library/papers/42120765PubMed
41889081
Association between the Zhejiang University index and metabolic dysfunction-associated fatty liver disease as analyzed in National Health and Nutrition Examination Survey: A retrospective observational study.
J Int Med Res2026https://conductscience.org/library/papers/41889081PubMed
41835374The relationship between triglyceride-glucose index, triglyceride-glucose-body mass index, and the severity of hepatic steatosis and liver fibrosis in patients with MASLD: a cross-sectional study.Front Nutr2026https://conductscience.org/library/papers/41835374PubMed
41810674NAFLD-related SNPs are linked to changes in liver fat, as measured by the CAP score, and serum lipids in response to a 3-week sugar-sweetened beverage intervention: a pilot study.Food Funct2026https://conductscience.org/library/papers/41810674PubMed
41792632The relationship between metabolic associated fatty liver disease and thyroid nodule: a cross-sectional study in China.BMC Gastroenterol2026https://conductscience.org/library/papers/41792632PubMed

See all 130 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35528971

GET https://conductscience.org/api/papers/v1/35528971/references?page=2